BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29
• 31

• Haemacure Corporation Shares to be Delisted from the Toronto Stock Exchange

  January 7, 2010

   · 

  1 min read
• Genetown

  HeartWare to Present at J.P. Morgan Healthcare Conference in San Francisco

  January 7, 2010

   · 

  1 min read
• BioForest

  Trubion Pharmaceuticals Inc. Announces Upcoming Presentation at OneMedForum 2010

  January 7, 2010

   · 

  1 min read
• Business

  Cell Medica Announces R&D Framework Agreement with the Center for Cell and Gene Therapy at Baylor College of Medicine

  January 7, 2010

   · 

  1 min read
• Drug Development

  Tolerx, Inc. Completes Enrollment in DEFEND-1, A Phase 3 Type 1 Diabetes Study With Otelixizumab

  January 7, 2010

   · 

  2 min read
• Drug Development

  Mechanism of Action for Vical Incorporated’s Vaxfectin(R) Adjuvant Expands Potential Applications

  January 7, 2010

   · 

  1 min read
• Business

  Constellation Pharmaceuticals Appoints Kerry K. Reinertsen, Ph.D. as Company’s Chief Business Officer

  January 7, 2010

   · 

  1 min read
• Bio NC

  TheraSim Secures $1.25 Million Investment From Andromeda Capital

  January 7, 2010

   · 

  1 min read
• Drug Development

  Novelos Therapeutics, Inc. Reaches 725th Event in Pivotal Phase 3 Lung Cancer Trial

  January 7, 2010

   · 

  1 min read
• Genetown

  Acceleron Pharma to Present at the 28th Annual J.P. Morgan Healthcare Conference

  January 7, 2010

   · 

  1 min read